semaglutide for alcoholism A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy, can reduce heavy drinking in adults with alcohol use disorder. Read more: https://www.forbes.com/sites/antoniopequenoiv/2026/07 semaglutide alcoholism Ozempic and Wegovy

Patients seeking a medically supervised weight-loss clinic in Milwaukee will value this provider-led approach, which supports safe, effective, and sustainable results

One systematic review and meta-analysis found that applying cold to the site before and after a subcutaneous injection of the blood thinner heparin reduced discomfort and bruising

Severe ECG disturbances (i.e., severe bradycardia and ST-elevation until asystole) were also reversed

Although still exploratory, these findings suggest that the Kyn/Trp ratio may warrant further evaluation as a potential marker for risk stratification in longitudinal studies